Drugs / CJ30001
last change Jul 2012 re-read 3 minutes ago

CJ30001

Developed for
type 2 diabetes mellitus
Investigated by
HK inno.N Corporation

Trials 3

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT01380873 Jan → Feb 2010 diabetes mellitus HK inno.N Corporation Completed No outcome recorded
Phase 1 NCT01370681 Oct → Nov 2009 diabetes mellitus HK inno.N Corporation Completed No outcome recorded
Phase 31 trial
Phase 3 NCT01370707 Apr 2011 → Jul 2012 type 2 diabetes mellitus HK inno.N Corporation Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as CJ30001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01380873 ↗
2

NCT01370707 ↗

NCT01370681 ↗